Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06095401 · ClinicalTrials.gov registry record · NA
Swelling Management After Knee Replacement
A NA study of Arthroplasties, Knee Replacement, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 2
- Study locations
NCT06095401 is a NA study of Arthroplasties, Knee Replacement that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 58 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT06095401, a NA study of Arthroplasties, Knee Replacement, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 2
- Study locations
Study Summary
To determine if inelastic adjustable compression garment results in improved surgical limb swelling control (bioimpedance assessment - primary outcome) after TKA compared to control (TED hose).
Conditions Studied
Interventions
- OTHER Inelastic adjustable compression garment (INCOM)
- OTHER Elastic compression garment (CONTROL)
Study Locations (2)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
- Colorado Joint Replacement - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06095401
The ClinicalTrials.gov registry entry for NCT06095401 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arthroplasties, Knee Replacement appearing as the primary indexed condition, and to 2 interventions - of which Inelastic adjustable compression garment (INCOM) is the first listed.
NCT06095401 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT06095401 about?
NCT06095401 is a clinical study titled "Swelling Management After Knee Replacement". To determine if inelastic adjustable compression garment results in improved surgical limb swelling control (bioimpedance assessment - primary outcome) after TKA compared to control (TED hose).
What is the current status of trial NCT06095401?
This trial is currently recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2024-02-21. Estimated completion is 2026-04-30.
What conditions does trial NCT06095401 study?
This clinical trial studies the following conditions: Arthroplasties, Knee Replacement.
What interventions are being tested in trial NCT06095401?
The interventions under investigation include: Inelastic adjustable compression garment (INCOM) (OTHER), Elastic compression garment (CONTROL) (OTHER).
Who is sponsoring clinical trial NCT06095401?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06095401 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasties, Knee Replacement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.